SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%

Bulletin Express

Jul 10

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026.

The shares were issued at HKD 470.20 each, implying gross proceeds of approximately HKD 2.75 billion. The new issuance represents 3.41% of SKB BIO’s previously issued share capital.

Following the placement: • Issued H shares (excluding treasury shares) rose from 170.98 million to 176.82 million. • No treasury shares were outstanding before or after the transaction. • No share repurchases or redemptions were reported.

The company stated that the placement was duly authorised by its board and executed in full compliance with Hong Kong Stock Exchange listing rules and all relevant regulatory requirements.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1180080507"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1180080507\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1180080507?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-10 17:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180080507","market":"hk","top_or_hot":-1,"title":"SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%","media":"Bulletin Express","content":"<p>Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026.</p>\n<p>The shares were issued at HKD 470.20 each, implying gross proceeds of approximately HKD 2.75 billion. The new issuance represents 3.41% of SKB BIO’s previously issued share capital.</p>\n<p>Following the placement:\n• Issued H shares (excluding treasury shares) rose from 170.98 million to 176.82 million.  \n• No treasury shares were outstanding before or after the transaction.  \n• No share repurchases or redemptions were reported.</p>\n<p>The company stated that the placement was duly authorised by its board and executed in full compliance with Hong Kong Stock Exchange listing rules and all relevant regulatory requirements.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-10 17:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026.</p>\n<p>The shares were issued at HKD 470.20 each, implying gross proceeds of approximately HKD 2.75 billion. The new issuance represents 3.41% of SKB BIO’s previously issued share capital.</p>\n<p>Following the placement:\n• Issued H shares (excluding treasury shares) rose from 170.98 million to 176.82 million.  \n• No treasury shares were outstanding before or after the transaction.  \n• No share repurchases or redemptions were reported.</p>\n<p>The company stated that the placement was duly authorised by its board and executed in full compliance with Hong Kong Stock Exchange listing rules and all relevant regulatory requirements.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06990","symbol_name":"科伦博泰生物","start_time":0,"source_url":"","article_id":"1180080507","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180080507","pubTimestamp":1783675345,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026. The shares were issued at HKD 470.20 each,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06990":"科伦博泰生物"},"translate_title":"SKB生物完成27.5亿港元H股配售，已发行股本扩大3.41%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06990":1},"content_text":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026.\nThe shares were issued at HKD 470.20 each, implying gross proceeds of approximately HKD 2.75 billion. The new issuance represents 3.41% of SKB BIO’s previously issued share capital.\nFollowing the placement:\n• Issued H shares (excluding treasury shares) rose from 170.98 million to 176.82 million.  \n• No treasury shares were outstanding before or after the transaction.  \n• No share repurchases or redemptions were reported.\nThe company stated that the placement was duly authorised by its board and executed in full compliance with Hong Kong Stock Exchange listing rules and all relevant regulatory requirements.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}